Preemptive alcohol septal ablation appears to lower the risk of life-threatening left ventricular outflow tract (LVOT) obstruction in select patients undergoing transcatheter mitral valve replacement ...

Background A 42-year-old woman with a 20-year history of obstructive hypertrophic cardiomyopathy was referred for alcohol septal ablation following a worsening of symptoms, which had persisted despite ...

The occurrence of high-grade conduction disturbances after alcohol septal ablation (ASA) did not translate into worse long-term survival for people with obstructive hypertrophic cardiomyopathy (HCM), ...

Please provide your email address to receive an email when new articles are posted on . Alcohol septal ablation for obstructive hypertrophic cardiomyopathy was associated with greater rate of 10-year ...

Over the long term, patients with obstructive hypertrophic cardiomyopathy (HCM) who require a permanent pacemaker after alcohol septal ablation (ASA) fare just as well as those who don’t, a ...

The unique beat of each person’s timed ticker has been pronounced just as identifiable as a fingerprint by some biotech companies. And while each heart may beat to a different rhythm, this rhythm ...

Please provide your email address to receive an email when new articles are posted on . In patients with obstructive hypertrophic cardiomyopathy, septal reduction therapy was associated with reduced ...

Treating patients with HCM is guided by how severe symptoms are, whether a patient has any risk factors for sudden cardiac death, and whether a patient has cardiac arrhythmias and other associated ...

—Surgical ventricular septal reduction or alcohol septal ablation therapy? A study in France tapped a nationwide database to better describe and compare the safety of the 2 septal reduction therapy ...

A University of Texas at Arlington multidisciplinary team will use a National Institutes of Health (NIH) grant to research new ways to improve the safety and effectiveness of medical procedures on ...

HANGZHOU, China, March 4, 2023 /PRNewswire/ -- On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen RF™ ...

A 42-year-old woman with obstructive hypertrophic cardiomyopathy (HCM) was referred for alcohol septal ablation (ASA). She had been diagnosed with HCM 20 years earlier following presentation with ...